News

David Dubrof Shares Insights on PBM Price Transparency for Work Comp Wire


In an article for Work Comp Wire, Chief Sales Officer David Dubrof talks PBM price transparency. For a long-term claims strategy and true cost control, strong pharmacy network relationships and clinical oversight are more important than chasing discounts and rebates.

Newly appointed myMatrixx Chief Sales Officer, David Dubrof, was featured in the most recent edition of Work Comp Wire’s Leaders Speak series, where he discussed emerging industry pricing trends. The article, “PBM Price Transparency — What You See Isn’t Always What You Get” covered the practice of some newer entrants promoting themselves as using “transparent” …

myMatrixx Names David Dubrof as Chief Sales Officer


In an article for Work Comp Wire, Chief Sales Officer David Dubrof talks PBM price transparency. For a long-term claims strategy and true cost control, strong pharmacy network relationships and clinical oversight are more important than chasing discounts and rebates.

myMatrixx, an Express Scripts Company today announced that David Dubrof has been named Chief Sales Officer for the organization. “We’re absolutely thrilled to have David join our team,” said Mike Cirillo, President of myMatrixx. “His 25-plus years of executive management experience in sales, marketing and operations in the workers’ compensation sector are a tremendous asset …

Phil Walls Quoted in Risk & Insurance on Medical Marijuana


Medical marijuana use continues to be a topic of debate in the workers’ compensation space, with states reviewing its legality and industry professionals trying to better understand its utility as a treatment. Recently, myMatrixx Chief Clinical Officer, Phil Walls, was quoted in an article for Risk & Insurance Magazine covering this subject. In the wide-ranging …

Update to Search for Safe and Effective COVID-19 Vaccines Document


  One of the top priorities for successfully mitigating COVID-19 is the development of an effective yet safe vaccine. Currently there are more than 100 potential vaccines in development, with projections for commercial availability a year or more away. To provide the latest information, myMatrixx is making regular updates to the “COVID-19 — Searching for …